首页 > 最新文献

Chemico-Biological Interactions最新文献

英文 中文
Unveiling the 4-aminoquinoline derivatives as potent agents against pancreatic ductal adenocarcinoma (PDAC) cell lines 揭示 4-氨基喹啉衍生物对胰腺导管腺癌(PDAC)细胞株的强效作用。
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-19 DOI: 10.1016/j.cbi.2024.111281
Marija Živanović , Milica Selaković , Aleksandar Pavić , Života Selaković , Bogdan Šolaja , Juan F. Santibanez , Tatjana Srdić-Rajić
Common antimalarials such as artemisinins, chloroquine and their derivatives also possess potent anti-inflamantory, antiviral and anticancer properties. In the search for new therapeutics to combat difficult-to-treat pancreatic carcinomas, we unveiled that 4-aminoquinoline derivatives, with significant antiplasmodial properties and a great safety profile in vivo, have remarkable anticancer activity against pancreatic ductal adenocarcinoma (PDAC) and considerable efficacy in the xenograft model in vivo. The aim of the present study was to further investigate anticancer properties of these compounds in a drug-repurposing manner. The compounds showed profound cytotoxic effects at nanomolar to low micromolar concentration in 2D cultured cells (in vitro) and in the zebrafish PDAC xenograft model (in vivo). A deeper insight into their mechanisms of cytotoxic action showed these compounds induce apoptosis while increasing reactive oxygen species levels along with autophagy inhibition. Additional investigation of the autophagy modulation proved that tested quinoline derivatives cause P62 and LC3-II accumulation in PDAC cells alongside lysosomal alkalinization. Further, in vivo toxicity studies in the zebrafish model showed low toxicity without developmental side effects of the investigated 4-aminoquinolines, while the applied compounds effectively inhibited tumor growth and prevented the metastasis of xenografted pancreatic cells. Taken together, these results highlight the 4-aminoquinolines as privileged structures that ought to be investigated further for potential application in pancreatic carcinoma treatment.
常见的抗疟药物,如青蒿素类、氯喹及其衍生物,也具有强大的抗炎、抗病毒和抗癌特性。在寻找对抗难以治疗的胰腺癌的新疗法过程中,我们发现 4-氨基喹啉衍生物具有显著的抗疟特性和良好的体内安全性,对胰腺导管腺癌(PDAC)具有显著的抗癌活性,并在体内异种移植模型中具有相当的疗效。本研究旨在以药物再利用的方式进一步研究这些化合物的抗癌特性。在二维培养细胞(体外)和斑马鱼 PDAC 异种移植模型(体内)中,这些化合物在纳摩尔至低微摩尔浓度下表现出了深远的细胞毒性效应。对其细胞毒性作用机制的深入研究表明,这些化合物在抑制自噬的同时,还能诱导细胞凋亡,同时增加活性氧水平。对自噬调节的进一步研究证明,测试的喹啉衍生物会导致 PDAC 细胞中 P62 和 LC3-II 的积累以及溶酶体碱化。此外,在斑马鱼模型中进行的体内毒性研究表明,所研究的 4-氨基喹啉类化合物毒性较低,不会对发育产生副作用。综上所述,这些结果突出表明 4-氨基喹啉类化合物具有特殊的结构,应进一步研究其在胰腺癌治疗中的潜在应用。
{"title":"Unveiling the 4-aminoquinoline derivatives as potent agents against pancreatic ductal adenocarcinoma (PDAC) cell lines","authors":"Marija Živanović ,&nbsp;Milica Selaković ,&nbsp;Aleksandar Pavić ,&nbsp;Života Selaković ,&nbsp;Bogdan Šolaja ,&nbsp;Juan F. Santibanez ,&nbsp;Tatjana Srdić-Rajić","doi":"10.1016/j.cbi.2024.111281","DOIUrl":"10.1016/j.cbi.2024.111281","url":null,"abstract":"<div><div>Common antimalarials such as artemisinins, chloroquine and their derivatives also possess potent anti-inflamantory, antiviral and anticancer properties. In the search for new therapeutics to combat difficult-to-treat pancreatic carcinomas, we unveiled that 4-aminoquinoline derivatives, with significant antiplasmodial properties and a great safety profile <em>in vivo</em>, have remarkable anticancer activity against pancreatic ductal adenocarcinoma (PDAC) and considerable efficacy in the xenograft model <em>in vivo</em>. The aim of the present study was to further investigate anticancer properties of these compounds in a drug-repurposing manner. The compounds showed profound cytotoxic effects at nanomolar to low micromolar concentration in 2D cultured cells (<em>in vitro</em>) and in the zebrafish PDAC xenograft model (<em>in vivo</em>). A deeper insight into their mechanisms of cytotoxic action showed these compounds induce apoptosis while increasing reactive oxygen species levels along with autophagy inhibition. Additional investigation of the autophagy modulation proved that tested quinoline derivatives cause P62 and LC3-II accumulation in PDAC cells alongside lysosomal alkalinization. Further, <em>in vivo</em> toxicity studies in the zebrafish model showed low toxicity without developmental side effects of the investigated 4-aminoquinolines, while the applied compounds effectively inhibited tumor growth and prevented the metastasis of xenografted pancreatic cells. Taken together, these results highlight the 4-aminoquinolines as privileged structures that ought to be investigated further for potential application in pancreatic carcinoma treatment.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111281"},"PeriodicalIF":4.7,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paracetamol suppresses neutrophilic oxygen radicals through competitive inhibition and scavenging 扑热息痛通过竞争性抑制和清除作用抑制中性粒细胞氧自由基。
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-19 DOI: 10.1016/j.cbi.2024.111283
Peter P. Smith , Ilaria J. Chicca , Jennifer L.J. Heaney , Maria Muchova , Farhat L. Khanim , Adrian M. Shields , Mark T. Drayson , Iain L.C. Chapple , Josefine Hirschfeld
Neutrophils, pivotal cells of innate and adaptive immune responses, employ reactive oxygen species (ROS) to combat pathogens and control gene expression. Paracetamol (acetaminophen) is widely used as an analgesic and antipyretic medication, yet its precise mechanisms of action are not yet fully understood. Here, we investigate the impact of both ingested and in-vitro paracetamol on neutrophil ROS activity, using flow cytometry and antioxidant assays. Our studies reveal that paracetamol significantly suppresses ROS activity ex-vivo in the short term. Additionally, both paracetamol and its metabolite N-acetyl-p-benzoquinone imine exhibited direct in vitro antioxidant effects, and paracetamol suppressed neutrophil extracellular trap formation ex vivo. These findings suggest a connection between paracetamol use and altered neutrophil responses, with potential implications for use in some patient groups, such as immunocompromised individuals. Further investigation into paracetamol's effects on neutrophil antimicrobial functions is warranted to elucidate possible risks, particularly when taken frequently or in conjunction with other treatments such as vaccinations.
中性粒细胞是先天性和适应性免疫反应的关键细胞,它们利用活性氧(ROS)来对抗病原体和控制基因表达。扑热息痛(对乙酰氨基酚)被广泛用作镇痛和解热药物,但其确切的作用机制尚未完全清楚。在此,我们利用流式细胞仪和抗氧化测定法研究了摄入和体外对乙酰氨基酚对中性粒细胞 ROS 活性的影响。我们的研究表明,扑热息痛能在短期内明显抑制体外 ROS 活性。此外,扑热息痛及其代谢物 N-acetyl-p-benzoquinone imine 都表现出直接的体外抗氧化作用,扑热息痛还能抑制体内中性粒细胞胞外陷阱的形成。这些发现表明,扑热息痛的使用与中性粒细胞反应的改变之间存在联系,对某些患者群体(如免疫力低下者)的使用具有潜在影响。有必要进一步研究扑热息痛对中性粒细胞抗菌功能的影响,以阐明可能存在的风险,尤其是在频繁服用或与疫苗接种等其他治疗同时使用时。
{"title":"Paracetamol suppresses neutrophilic oxygen radicals through competitive inhibition and scavenging","authors":"Peter P. Smith ,&nbsp;Ilaria J. Chicca ,&nbsp;Jennifer L.J. Heaney ,&nbsp;Maria Muchova ,&nbsp;Farhat L. Khanim ,&nbsp;Adrian M. Shields ,&nbsp;Mark T. Drayson ,&nbsp;Iain L.C. Chapple ,&nbsp;Josefine Hirschfeld","doi":"10.1016/j.cbi.2024.111283","DOIUrl":"10.1016/j.cbi.2024.111283","url":null,"abstract":"<div><div>Neutrophils, pivotal cells of innate and adaptive immune responses, employ reactive oxygen species (ROS) to combat pathogens and control gene expression. Paracetamol (acetaminophen) is widely used as an analgesic and antipyretic medication, yet its precise mechanisms of action are not yet fully understood. Here, we investigate the impact of both ingested and <em>in-vitro</em> paracetamol on neutrophil ROS activity, using flow cytometry and antioxidant assays. Our studies reveal that paracetamol significantly suppresses ROS activity <em>ex-vivo</em> in the short term. Additionally, both paracetamol and its metabolite N-acetyl-<em>p</em>-benzoquinone imine exhibited direct <em>in vitro</em> antioxidant effects, and paracetamol suppressed neutrophil extracellular trap formation <em>ex vivo</em>. These findings suggest a connection between paracetamol use and altered neutrophil responses, with potential implications for use in some patient groups, such as immunocompromised individuals. Further investigation into paracetamol's effects on neutrophil antimicrobial functions is warranted to elucidate possible risks, particularly when taken frequently or in conjunction with other treatments such as vaccinations.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111283"},"PeriodicalIF":4.7,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperbaric oxygen rapidly produces intracellular bioenergetics dysfunction in human pulmonary cells 高压氧迅速导致人类肺细胞的细胞内生物能失调
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-18 DOI: 10.1016/j.cbi.2024.111266
Tanvir Hossain , Jackson T. Secor , David M. Eckmann
Hyperoxic exposure lasting days alters mitochondrial bioenergetic and dynamic functions in pulmonary cells as indices of oxygen toxicity. The aim of this study was to examine effects of short duration hyperbaric and hyperoxic exposures to induce oxygen toxicity similarly. Cultured human lung microvascular endothelial cells, human pulmonary artery endothelial cells and A549 cells were exposed to hyperoxia (∼5 % CO2 equivalent, balance O2) under hyperbaric conditions (4.8 ATA) for 1 and 4 h. Measures of mitochondrial dynamics, inner membrane potential, mitochondrial respiration, the intracellular distribution of bioenergetic capacity and respiration complex protein levels were then quantified. Exposures resulted in altered mitochondrial motility, presence of inhomogeneities in respiration parameters, loss of inner membrane potential, and changes in intracellular partitioning of ATP-linked respiration. Changes in the levels of respiration complex protein levels were also found. The combination of hyperoxic exposure with hyperbaric conditions rapidly produced changes in mitochondrial dynamics and bioenergetics in pulmonary cells. These changes are consistent with the onset of pulmonary oxygen toxicity previously known to result from long duration exposure to hyperoxia alone. These findings suggest health caution is warranted in environmental settings in which both hyperoxic and hyperbaric conditions are present. The synergism of hyperoxia and hyperbaria for rapid induction of oxygen toxicity in cellular models has utility for the study of mechanistic determinants of oxygen toxicity, testing of putative therapeutics, and associated investigations of mitochondrial dysfunction.
持续数天的高氧暴露会改变肺细胞线粒体的生物能和动态功能,这是氧气毒性的指标。本研究的目的是研究短期高压氧和高氧暴露对诱发氧毒性的影响。将培养的人肺微血管内皮细胞、人肺动脉内皮细胞和 A549 细胞暴露于高压氧条件(4.8 ATA)下的高氧(∼ 5%二氧化碳当量,平衡氧气)中 1 小时和 4 小时。然后对线粒体动力学、内膜电位、线粒体呼吸、生物能的细胞内分布和呼吸复合蛋白水平进行量化。暴露导致线粒体运动发生改变、呼吸参数出现不均匀性、内膜电位丧失以及与 ATP 相关的呼吸在细胞内的分布发生变化。呼吸复合蛋白水平也发生了变化。高氧暴露与高压氧条件相结合,迅速导致肺细胞线粒体动力学和生物能发生变化。这些变化与之前已知的仅因长时间暴露于高氧环境而导致肺氧中毒的情况一致。这些研究结果表明,在同时存在高氧和高压氧条件的环境中,应谨慎对待健康问题。在细胞模型中,高氧和高压氧的协同作用可快速诱导氧毒性,这对于研究氧毒性的机理决定因素、测试可能的治疗方法以及线粒体功能障碍的相关研究都很有用。
{"title":"Hyperbaric oxygen rapidly produces intracellular bioenergetics dysfunction in human pulmonary cells","authors":"Tanvir Hossain ,&nbsp;Jackson T. Secor ,&nbsp;David M. Eckmann","doi":"10.1016/j.cbi.2024.111266","DOIUrl":"10.1016/j.cbi.2024.111266","url":null,"abstract":"<div><div>Hyperoxic exposure lasting days alters mitochondrial bioenergetic and dynamic functions in pulmonary cells as indices of oxygen toxicity. The aim of this study was to examine effects of short duration hyperbaric and hyperoxic exposures to induce oxygen toxicity similarly. Cultured human lung microvascular endothelial cells, human pulmonary artery endothelial cells and A549 cells were exposed to hyperoxia (∼5 % CO<sub>2</sub> equivalent, balance O<sub>2</sub>) under hyperbaric conditions (4.8 ATA) for 1 and 4 h. Measures of mitochondrial dynamics, inner membrane potential, mitochondrial respiration, the intracellular distribution of bioenergetic capacity and respiration complex protein levels were then quantified. Exposures resulted in altered mitochondrial motility, presence of inhomogeneities in respiration parameters, loss of inner membrane potential, and changes in intracellular partitioning of ATP-linked respiration. Changes in the levels of respiration complex protein levels were also found. The combination of hyperoxic exposure with hyperbaric conditions rapidly produced changes in mitochondrial dynamics and bioenergetics in pulmonary cells. These changes are consistent with the onset of pulmonary oxygen toxicity previously known to result from long duration exposure to hyperoxia alone. These findings suggest health caution is warranted in environmental settings in which both hyperoxic and hyperbaric conditions are present. The synergism of hyperoxia and hyperbaria for rapid induction of oxygen toxicity in cellular models has utility for the study of mechanistic determinants of oxygen toxicity, testing of putative therapeutics, and associated investigations of mitochondrial dysfunction.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111266"},"PeriodicalIF":4.7,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aristolochic acid I induced mitochondrial Ca2+ accumulation triggers the production of MitoROS and activates Src/FAK pathway in hepatocellular carcinoma cells 马兜铃酸 I 诱导的线粒体 Ca2+ 积累会触发肝癌细胞产生 MitoROS 并激活 Src/FAK 通路。
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-18 DOI: 10.1016/j.cbi.2024.111269
Yongkang Hu, Qi Zhang, Wenjuan Jiang, Xian Wang, Xinlong Guo, Langqun Chen, Siyu Cheng, Jiahui Ying, Jing Ye , Liang Zhang
Aristolochic acid I (AAI) is one of the nephrotoxic and carcinogenic compounds in Aristolochic acids (AAs). Recent studies have reported its promoting effect on hepatocellular carcinoma. However, the underlying mechanisms of AAI for the development of HCC is still unclear. Here, we found that AAI exposure caused alterations in mitochondrial function, which featured with increased ATP level and mitochondrial membrane potential, accumulation of mitochondrial Ca2+ and mitochondrial ROS (MitoROS) in Hepa1-6 and HepG2 cells. The restriction of mitochondrial Ca2+ uptake alleviated these effects. Our results showed that increased MitoROS was associated with AAI-induced migration and invasion in HCC cells. MitoROS/Src/FAK pathway was involved in the AAI-induced migration and invasion of HCC cells. In summary, our study showed that AAI affected mitochondrial metabolism of HCC cells by promoting the accumulation of mitochondrial Ca2+. These effects resulted in the activation of the MitoROS/SRC/FAK pathway in AAI-treated HCC cells, which in turn induced cell migration and invasion.
马兜铃酸 I(AAI)是马兜铃酸(AAs)中具有肾毒性和致癌性的化合物之一。最近有研究报告称,AAI 对肝细胞癌有促进作用。然而,AAI 导致 HCC 发生的潜在机制仍不清楚。在这里,我们发现暴露于 AAI 会引起线粒体功能的改变,其特征是 ATP 水平和线粒体膜电位升高、线粒体 Ca2+ 和线粒体 ROS(MitoROS)在 Hepa1-6 和 HepG2 细胞中积累。限制线粒体 Ca2+ 摄取可减轻这些影响。我们的研究结果表明,MitoROS的增加与AAI诱导的HCC细胞迁移和侵袭有关。MitoROS/Src/FAK通路参与了AAI诱导的HCC细胞迁移和侵袭。总之,我们的研究表明,AAI 通过促进线粒体 Ca2+ 的积累影响了 HCC 细胞的线粒体代谢。这些影响导致 AAI 处理的 HCC 细胞中的 MitoROS/SRC/FAK 通路被激活,进而诱导细胞迁移和侵袭。
{"title":"Aristolochic acid I induced mitochondrial Ca2+ accumulation triggers the production of MitoROS and activates Src/FAK pathway in hepatocellular carcinoma cells","authors":"Yongkang Hu,&nbsp;Qi Zhang,&nbsp;Wenjuan Jiang,&nbsp;Xian Wang,&nbsp;Xinlong Guo,&nbsp;Langqun Chen,&nbsp;Siyu Cheng,&nbsp;Jiahui Ying,&nbsp;Jing Ye ,&nbsp;Liang Zhang","doi":"10.1016/j.cbi.2024.111269","DOIUrl":"10.1016/j.cbi.2024.111269","url":null,"abstract":"<div><div>Aristolochic acid I (AAI) is one of the nephrotoxic and carcinogenic compounds in Aristolochic acids (AAs). Recent studies have reported its promoting effect on hepatocellular carcinoma. However, the underlying mechanisms of AAI for the development of HCC is still unclear. Here, we found that AAI exposure caused alterations in mitochondrial function, which featured with increased ATP level and mitochondrial membrane potential, accumulation of mitochondrial Ca<sup>2+</sup> and mitochondrial ROS (MitoROS) in Hepa1-6 and HepG2 cells. The restriction of mitochondrial Ca<sup>2+</sup> uptake alleviated these effects. Our results showed that increased MitoROS was associated with AAI-induced migration and invasion in HCC cells. MitoROS/Src/FAK pathway was involved in the AAI-induced migration and invasion of HCC cells. In summary, our study showed that AAI affected mitochondrial metabolism of HCC cells by promoting the accumulation of mitochondrial Ca<sup>2+</sup>. These effects resulted in the activation of the MitoROS/SRC/FAK pathway in AAI-treated HCC cells, which in turn induced cell migration and invasion.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"405 ","pages":"Article 111269"},"PeriodicalIF":4.7,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-induced inflammation: A review of literature 药物诱发的炎症:文献综述。
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-18 DOI: 10.1016/j.cbi.2024.111282
Yoshiyasu Takefuji
This review examines how various medications can trigger inflammation throughout the body. It explores causes, ranging from common pain relievers like NSAIDs to chemotherapy drugs. The review also highlights potential treatments, including established medications and promising new therapies. Physicians and patients can work together to reduce this risk by understanding these causes and implementing preventive measures, such as monitoring for side effects and using alternative medications when possible. Drug-induced inflammation can be categorized into four types based on the immune response involved. Symptoms vary by type and affected organ. Common symptoms include fever, malaise, joint pain, rash, and swelling. Diagnosis involves blood tests, imaging, and biopsies. Treatment primarily involves discontinuing the suspected drug and providing supportive care. The development of new drugs and therapies has made diagnosis challenging. However, recent advances in biomarkers and genetic risk assessment techniques are improving diagnosis and risk assessment of drug-induced liver injury. Preventive measures for drug-induced inflammation include monitoring for side effects, using alternative medications, developing new drug delivery methods, exploring new anti-inflammatory drugs, being aware of rare side effects, and understanding the underlying mechanisms.
这篇综述探讨了各种药物如何引发全身炎症。它探讨了从非甾体抗炎药等常见止痛药到化疗药物的各种原因。综述还重点介绍了潜在的治疗方法,包括已有的药物和前景看好的新疗法。医生和患者可以通过了解这些原因并采取预防措施,如监测副作用和尽可能使用替代药物,来共同降低这种风险。根据所涉及的免疫反应,药物引起的炎症可分为四种类型。不同类型和受影响器官的症状各不相同。常见症状包括发热、不适、关节疼痛、皮疹和肿胀。诊断包括血液化验、影像学检查和活组织检查。治疗主要包括停用可疑药物和提供支持性护理。新药和新疗法的开发使诊断变得具有挑战性。不过,生物标志物和遗传风险评估技术的最新进展正在改善药物性肝损伤的诊断和风险评估。药物性炎症的预防措施包括监测副作用、使用替代药物、开发新的给药方法、探索新的抗炎药物、注意罕见的副作用以及了解潜在的机制。
{"title":"Drug-induced inflammation: A review of literature","authors":"Yoshiyasu Takefuji","doi":"10.1016/j.cbi.2024.111282","DOIUrl":"10.1016/j.cbi.2024.111282","url":null,"abstract":"<div><div>This review examines how various medications can trigger inflammation throughout the body. It explores causes, ranging from common pain relievers like NSAIDs to chemotherapy drugs. The review also highlights potential treatments, including established medications and promising new therapies. Physicians and patients can work together to reduce this risk by understanding these causes and implementing preventive measures, such as monitoring for side effects and using alternative medications when possible. Drug-induced inflammation can be categorized into four types based on the immune response involved. Symptoms vary by type and affected organ. Common symptoms include fever, malaise, joint pain, rash, and swelling. Diagnosis involves blood tests, imaging, and biopsies. Treatment primarily involves discontinuing the suspected drug and providing supportive care. The development of new drugs and therapies has made diagnosis challenging. However, recent advances in biomarkers and genetic risk assessment techniques are improving diagnosis and risk assessment of drug-induced liver injury. Preventive measures for drug-induced inflammation include monitoring for side effects, using alternative medications, developing new drug delivery methods, exploring new anti-inflammatory drugs, being aware of rare side effects, and understanding the underlying mechanisms.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111282"},"PeriodicalIF":4.7,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxymatrine inhibits migration and invasion of esophageal squamous cell carcinoma cell lines via the MEK1/ERK/β-catenin pathway 氧化苦参碱通过 MEK1/ERK/β-catenin 通路抑制食管鳞状细胞癌细胞株的迁移和侵袭
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-16 DOI: 10.1016/j.cbi.2024.111270
Baoshi Xu , Tian Qiu , Rongrong Yang , Jingchao Qiang , Yongliang Yang , Mengyuan Zhou , Xing Li , Jingquan Dong , Yingzhi Lu , Zibo Dong
Esophageal, cancer is a prevalent malignant tumour of the digestive system in China, and esophageal squamous cell carcinoma (ESCC) accounts for 90 % of all esophageal cancer cases. Currently, the primary treatment involves surgical resection combined with postoperative radiotherapy. In this study, we used two ESCC cell lines to determine whether oxymatrine (OMT) inhibits ESCC, whether the mechanism involves the MEK1/ERK/β-catenin pathway, and how OMT modulates this pathway to affect the development of ESCC. The effects of OMT treatment were monitored with Cell Counting Kit-8 (CCK-8) assays as well as with clony formation, migration and invasion, wound healing, Hoechst 33258, and Western blot analyses. The relationship between OMT and the target was also evaluated by molecular docking and cell stability experiments. These findings suggest that ESCC development and metastasis may be inhibited by OMT and that OMT targets MEK1 through the ERK/β-catenin/EMT pathway to suppress ESCC cell migration and invasion. In addition, in vivo studies confirmed that OMT can inhibit the growth of ESCC cell lines in NOG mice without causing damage to other organs. In conclusion, in vitro experiments, revealed that OMT prevents the migration and invasiveness of ESCC cells by inhibiting the ERK/β-catenin/EMT pathway and thus targeting MAP2K1 (MEK1) in ESCC.
食管癌是中国常见的消化系统恶性肿瘤,食管鳞状细胞癌(ESCC)占食管癌病例总数的 90%。目前,主要的治疗方法是手术切除结合术后放疗。在这项研究中,我们利用两种 ESCC 细胞系来确定氧化苦参碱(OMT)是否能抑制 ESCC,其机制是否涉及 MEK1/ERK/β-catenin 通路,以及 OMT 如何调节该通路以影响 ESCC 的发展。研究人员通过细胞计数试剂盒-8(CCK-8)测定、克隆形成、迁移和侵袭、伤口愈合、Hoechst 33258和Western印迹分析来监测OMT治疗的效果。此外,还通过分子对接和细胞稳定性实验评估了 OMT 与靶标之间的关系。这些研究结果表明,OMT可抑制ESCC的发展和转移,OMT通过ERK/β-catenin/EMT通路靶向MEK1,从而抑制ESCC细胞的迁移和侵袭。此外,体内研究证实,OMT 可抑制 ESCC 细胞株在 NOG 小鼠体内的生长,且不会对其他器官造成损伤。总之,体外实验表明,OMT通过抑制ERK/β-catenin/EMT通路,从而靶向ESCC中的MAP2K1(MEK1),阻止了ESCC细胞的迁移和侵袭。
{"title":"Oxymatrine inhibits migration and invasion of esophageal squamous cell carcinoma cell lines via the MEK1/ERK/β-catenin pathway","authors":"Baoshi Xu ,&nbsp;Tian Qiu ,&nbsp;Rongrong Yang ,&nbsp;Jingchao Qiang ,&nbsp;Yongliang Yang ,&nbsp;Mengyuan Zhou ,&nbsp;Xing Li ,&nbsp;Jingquan Dong ,&nbsp;Yingzhi Lu ,&nbsp;Zibo Dong","doi":"10.1016/j.cbi.2024.111270","DOIUrl":"10.1016/j.cbi.2024.111270","url":null,"abstract":"<div><div>Esophageal, cancer is a prevalent malignant tumour of the digestive system in China, and esophageal squamous cell carcinoma (ESCC) accounts for 90 % of all esophageal cancer cases. Currently, the primary treatment involves surgical resection combined with postoperative radiotherapy. In this study, we used two ESCC cell lines to determine whether oxymatrine (OMT) inhibits ESCC, whether the mechanism involves the MEK1/ERK/β-catenin pathway, and how OMT modulates this pathway to affect the development of ESCC. The effects of OMT treatment were monitored with Cell Counting Kit-8 (CCK-8) assays as well as with clony formation, migration and invasion, wound healing, Hoechst 33258, and Western blot analyses. The relationship between OMT and the target was also evaluated by molecular docking and cell stability experiments. These findings suggest that ESCC development and metastasis may be inhibited by OMT and that OMT targets MEK1 through the ERK/β-catenin/EMT pathway to suppress ESCC cell migration and invasion. In addition, in vivo studies confirmed that OMT can inhibit the growth of ESCC cell lines in NOG mice without causing damage to other organs. In conclusion, in vitro experiments, revealed that OMT prevents the migration and invasiveness of ESCC cells by inhibiting the ERK/β-catenin/EMT pathway and thus targeting MAP2K1 (MEK1) in ESCC.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111270"},"PeriodicalIF":4.7,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142446626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The assessment of the phototoxic potential of drugs forming complexes with melanin - Screening in vitro studies using normal skin cells with varying pigmentation irradiated by a sunlight simulator 评估与黑色素形成复合物的药物的光毒性潜力--使用模拟日光照射的不同色素沉着的正常皮肤细胞进行体外筛选研究
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-11 DOI: 10.1016/j.cbi.2024.111268
Jakub Rok, Justyna Kowalska, Zuzanna Rzepka, Klaudia Banach, Dorota Wrześniok
Phototoxic reactions are among the most common skin-related adverse effects induced by drugs. It is believed that the binding of chemicals to melanin biopolymers is a significant factor influencing skin toxicity. The formation of drug-melanin complexes can lead to the accumulation of drugs or their photodegradation products in pigmented cells, potentially affecting phototoxic reactions. Current procedures for assessing the phototoxic potential of drugs are based on tests using immortalized mouse fibroblasts.
This study aimed to assess the phototoxic potential of selected drugs that form complexes with melanin (chloroquine, chlorpromazine, doxycycline) using human melanocytes with varying degrees of pigmentation. Parallel research was conducted on human dermal fibroblasts. To induce phototoxicity, cell cultures were irradiated using a sunlight simulator (5 J/cm2 for UVA spectrum). To account for the process of drug accumulation, two experimental models with different incubation times of cells with drugs before irradiation were used. The photo-irritation factor (PIF) was calculated based on NRU and WST-1 screening tests. Additionally, cell viability was examined cytometrically, and analyses of the cell cycle and reduced glutathione levels were conducted.
The results indicated that drugs binding with melanin exhibited different levels of cytotoxicity and phototoxicity towards fibroblasts and melanocytes. These observed differences impact the values of PIF, potentially complicating the interpretation of the studies. Additional analyses, such as examining cell subpopulations in the sub-G1 phase and determining the level of reduced glutathione, can enhance the assessment of the phototoxicity of drugs on pigmented cells.
光毒性反应是药物诱发的最常见的皮肤相关不良反应之一。人们认为,化学物质与黑色素生物聚合物的结合是影响皮肤毒性的一个重要因素。药物与黑色素复合物的形成会导致药物或其光降解产物在色素细胞中积聚,从而可能影响光毒性反应。目前评估药物光毒性潜力的程序是基于使用永生小鼠成纤维细胞进行的测试。本研究旨在使用不同色素沉着程度的人类黑色素细胞,评估与黑色素形成复合物的特定药物(氯喹、氯丙嗪、强力霉素)的光毒性潜力。与此同时,还对人类真皮成纤维细胞进行了研究。为了诱导光毒性,使用太阳光模拟器(UVA 光谱为 5 J/cm2)照射细胞培养物。为了考虑药物积累的过程,使用了两种实验模型,即在照射前细胞与药物的孵育时间不同。光刺激因子(PIF)是根据 NRU 和 WST-1 筛选测试计算得出的。结果表明,与黑色素结合的药物对成纤维细胞和黑色素细胞具有不同程度的细胞毒性和光毒性。这些观察到的差异影响了 PIF 值,可能会使研究解释复杂化。额外的分析,如检查处于亚 G1 期的细胞亚群和确定还原型谷胱甘肽的水平,可加强对药物对色素细胞的光毒性的评估。
{"title":"The assessment of the phototoxic potential of drugs forming complexes with melanin - Screening in vitro studies using normal skin cells with varying pigmentation irradiated by a sunlight simulator","authors":"Jakub Rok,&nbsp;Justyna Kowalska,&nbsp;Zuzanna Rzepka,&nbsp;Klaudia Banach,&nbsp;Dorota Wrześniok","doi":"10.1016/j.cbi.2024.111268","DOIUrl":"10.1016/j.cbi.2024.111268","url":null,"abstract":"<div><div>Phototoxic reactions are among the most common skin-related adverse effects induced by drugs. It is believed that the binding of chemicals to melanin biopolymers is a significant factor influencing skin toxicity. The formation of drug-melanin complexes can lead to the accumulation of drugs or their photodegradation products in pigmented cells, potentially affecting phototoxic reactions. Current procedures for assessing the phototoxic potential of drugs are based on tests using immortalized mouse fibroblasts.</div><div>This study aimed to assess the phototoxic potential of selected drugs that form complexes with melanin (chloroquine, chlorpromazine, doxycycline) using human melanocytes with varying degrees of pigmentation. Parallel research was conducted on human dermal fibroblasts. To induce phototoxicity, cell cultures were irradiated using a sunlight simulator (5 J/cm<sup>2</sup> for UVA spectrum). To account for the process of drug accumulation, two experimental models with different incubation times of cells with drugs before irradiation were used. The photo-irritation factor (PIF) was calculated based on NRU and WST-1 screening tests. Additionally, cell viability was examined cytometrically, and analyses of the cell cycle and reduced glutathione levels were conducted.</div><div>The results indicated that drugs binding with melanin exhibited different levels of cytotoxicity and phototoxicity towards fibroblasts and melanocytes. These observed differences impact the values of PIF, potentially complicating the interpretation of the studies. Additional analyses, such as examining cell subpopulations in the sub-G1 phase and determining the level of reduced glutathione, can enhance the assessment of the phototoxicity of drugs on pigmented cells.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111268"},"PeriodicalIF":4.7,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of ponatinib metabolism and drug-drug interactions with lycopene and shikonin in vitro and in vivo 体外和体内波纳替尼代谢及与番茄红素和柚皮苷的药物相互作用研究
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-11 DOI: 10.1016/j.cbi.2024.111265
Jie Chen , Fengsheng Hong , Hailun Xia , Yuxin Shen , Xiaohai Chen , Hualu Wu , Guanyang Lin , Ruanjuan Zhan
Ponatinib is approved for use in patients with chronic myeloid leukemia (CML) who are resistant to or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. Given that ponatinib can induce significant cardiotoxicity when taken, and that most Chinese medicines have cardioprotective effects, it is possible to administer them in combination in clinic to alleviate adverse effects. The quantitative determination of ponatinib and its metabolite N-desmethyl ponatinib was optimized and fully verified by ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). And the drug-drug interactions (DDI) of ponatinib with lycopene and shikonin, both in vivo and in vitro, were studied. The results of bioanalytical methodology showed that ponatinib and N-desmethyl ponatinib had good linearity in plasma samples, and their selectivity, accuracy, precision, stability, matrix effect and recovery were all satisfied with the need of quantitative analysis of samples. In animal experiments, compared with the control group, lycopene and shikonin significantly changed the pharmacokinetic parameters of ponatinib, including AUC(0-t), AUC(0-∞) and CLz/F, while having no effect on the pharmacokinetic parameters of N-desmethyl ponatinib. In vitro interaction studies indicated that lycopene showed mixed inhibition mechanism on ponatinib metabolism in both rat liver microsomes (RLM) and human liver microsomes (HLM). And, shikonin displayed mixed inhibition mechanism in RLM and competitive inhibition mechanism in HLM, respectively. In summary, the UPLC-MS/MS method can accurately and sensitively quantify ponatinib and N-desmethyl ponatinib, and provide further reference for clinical drug combination between ponatinib and lycopene or shikonin.
波纳替尼被批准用于对之前的酪氨酸激酶抑制剂(TKI)治疗耐药或不耐受的慢性髓性白血病(CML)患者。鉴于服用泊纳替尼会引起明显的心脏毒性,而大多数中药都有保护心脏的作用,因此在临床上可以联合用药以减轻不良反应。该研究采用超高效液相色谱-串联质谱法(UPLC-MS/MS)对泊纳替尼及其代谢物N-去甲基泊纳替尼进行了优化和定量检测。此外,还研究了泊纳替尼与番茄红素和石杉碱甲在体内和体外的药物相互作用(DDI)。生物分析方法的结果表明,泊纳替尼和N-去甲基泊纳替尼在血浆样品中具有良好的线性关系,其选择性、准确性、精密度、稳定性、基质效应和回收率均能满足样品定量分析的需要。在动物实验中,与对照组相比,番茄红素和志贺宁显著改变了泊纳替尼的药代动力学参数,包括AUC(0-t)、AUC(0-∞)和CLz/F,而对N-去甲基泊纳替尼的药代动力学参数没有影响。体外相互作用研究表明,番茄红素对大鼠肝微粒体(RLM)和人肝微粒体(HLM)中的泊纳替尼代谢具有混合抑制机制。在大鼠肝脏微粒体(RLM)和人肝脏微粒体(HLM)中,紫檀素对泊那替尼的代谢均表现出混合抑制机制,而在HLM中则表现出竞争抑制机制。综上所述,UPLC-MS/MS方法能准确、灵敏地定量检测泊纳替尼和N-去甲基泊纳替尼,为临床上泊纳替尼与番茄红素或紫杉素联合用药提供了进一步的参考。
{"title":"Investigation of ponatinib metabolism and drug-drug interactions with lycopene and shikonin in vitro and in vivo","authors":"Jie Chen ,&nbsp;Fengsheng Hong ,&nbsp;Hailun Xia ,&nbsp;Yuxin Shen ,&nbsp;Xiaohai Chen ,&nbsp;Hualu Wu ,&nbsp;Guanyang Lin ,&nbsp;Ruanjuan Zhan","doi":"10.1016/j.cbi.2024.111265","DOIUrl":"10.1016/j.cbi.2024.111265","url":null,"abstract":"<div><div>Ponatinib is approved for use in patients with chronic myeloid leukemia (CML) who are resistant to or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. Given that ponatinib can induce significant cardiotoxicity when taken, and that most Chinese medicines have cardioprotective effects, it is possible to administer them in combination in clinic to alleviate adverse effects. The quantitative determination of ponatinib and its metabolite N-desmethyl ponatinib was optimized and fully verified by ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). And the drug-drug interactions (DDI) of ponatinib with lycopene and shikonin, both <em>in vivo</em> and <em>in vitro</em><em>,</em> were studied. The results of bioanalytical methodology showed that ponatinib and N-desmethyl ponatinib had good linearity in plasma samples, and their selectivity, accuracy, precision, stability, matrix effect and recovery were all satisfied with the need of quantitative analysis of samples. In animal experiments, compared with the control group, lycopene and shikonin significantly changed the pharmacokinetic parameters of ponatinib, including AUC<sub>(0-t)</sub>, AUC<sub>(0-∞)</sub> and CL<sub>z/F</sub>, while having no effect on the pharmacokinetic parameters of N-desmethyl ponatinib. <em>In vitro</em> interaction studies indicated that lycopene showed mixed inhibition mechanism on ponatinib metabolism in both rat liver microsomes (RLM) and human liver microsomes (HLM). And, shikonin displayed mixed inhibition mechanism in RLM and competitive inhibition mechanism in HLM, respectively. In summary, the UPLC-MS/MS method can accurately and sensitively quantify ponatinib and N-desmethyl ponatinib, and provide further reference for clinical drug combination between ponatinib and lycopene or shikonin.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111265"},"PeriodicalIF":4.7,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isavuconazonium sulfate induces heart development defects in zebrafish larvae by upregulation of oxidative stress 硫酸异芥子铵通过上调氧化应激诱导斑马鱼幼体心脏发育缺陷。
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-11 DOI: 10.1016/j.cbi.2024.111267
Qiang Yuan , Li Zhang , Yehao Li , Zhipeng Wang , Jiejun liu , Weitao Hu , Yihui Hu , Fasheng Liu , Shouhua Zhang , Xinjun Liao , Juhua Xiao , Zigang Cao
Environmental pollution remains a pressing global concern, with a substantial number of annual fatalities attributed to pollution-induced diseases. One emerging facet of environmental pollution is drug contamination, whereby pharmaceutical compounds can readily infiltrate water sources during manufacturing or utilization, subsequently being detected in various aquatic ecosystems. Some drugs have been detected in many watersheds at concentrations that can cause toxicity to aquatic organisms. Isavuconazonium sulfate (ISAV-SF), a prevalent antifungal medication, is no exception, warranting an exploration of its potential toxicity. However, limited research has been conducted in this domain. In this investigation, zebrafish were employed as a model organism to scrutinize the cardiotoxicity of ISAV-SF. Exposure of zebrafish embryos to concentrations of 0.5, 0.75, and 1 mg/L of ISAV-SF resulted in noteworthy cardiac developmental aberrations. These anomalies encompassed enlarged pericardial area, diminished heart rate, alterations in SV-BA distance, and the detachment of cardiomyocytes from the endocardium. Exposure to ISAV-SF caused disruption of the expression of genes related to cardiac development (gata4, klf2a, nkx2.5, vmhc, tbx2b), especially in the high concentration group. Moreover, the Notch signaling pathway was inhibited and oxidative stress levels were upregulated in all exposed groups. Remarkably, the administration of the antioxidant astaxanthin effectively mitigated oxidative stress levels, thus ameliorating heart developmental impairments. These results suggest that ISAV-SF may contribute to cardiac developmental defects by upregulating oxidative stress. This study serves as a pivotal reference for the utilization of ISAV-SF within the market, emphasizing the necessity to curtail its introduction into aquatic environments during production and consumption and to evaluate its repercussions on aquatic organisms.
环境污染仍然是全球亟待解决的问题,每年都有大量人员死于污染引发的疾病。环境污染的一个新方面是药物污染,药物化合物在生产或使用过程中很容易渗入水源,随后在各种水生生态系统中被检测到。在许多流域都检测到了一些药物,其浓度可对水生生物造成毒性。常见的抗真菌药物硫酸异琥珀酰亚胺(ISAV-SF)也不例外,因此有必要对其潜在毒性进行研究。然而,这方面的研究还很有限。在这项研究中,斑马鱼被用作研究 ISAV-SF 心脏毒性的模式生物。斑马鱼胚胎暴露于 0.5、0.75 和 1 毫克/升浓度的 ISAV-SF 后,会出现显著的心脏发育畸变。这些异常包括心包面积增大、心率减慢、SV-BA 距离改变以及心肌细胞从心内膜脱离。暴露于ISAV-SF会导致与心脏发育相关的基因(gata4、klf2a、nkx2.5、vmhc、tbx2b)表达紊乱,尤其是在高浓度组。此外,在所有暴露组中,Notch 信号通路受到抑制,氧化应激水平上调。值得注意的是,服用抗氧化剂虾青素可有效缓解氧化应激水平,从而改善心脏发育障碍。这些结果表明,ISAV-SF可能通过上调氧化应激导致心脏发育缺陷。这项研究为在市场上使用 ISAV-SF 提供了重要参考,强调了在生产和消费过程中减少将其引入水生环境并评估其对水生生物影响的必要性。
{"title":"Isavuconazonium sulfate induces heart development defects in zebrafish larvae by upregulation of oxidative stress","authors":"Qiang Yuan ,&nbsp;Li Zhang ,&nbsp;Yehao Li ,&nbsp;Zhipeng Wang ,&nbsp;Jiejun liu ,&nbsp;Weitao Hu ,&nbsp;Yihui Hu ,&nbsp;Fasheng Liu ,&nbsp;Shouhua Zhang ,&nbsp;Xinjun Liao ,&nbsp;Juhua Xiao ,&nbsp;Zigang Cao","doi":"10.1016/j.cbi.2024.111267","DOIUrl":"10.1016/j.cbi.2024.111267","url":null,"abstract":"<div><div>Environmental pollution remains a pressing global concern, with a substantial number of annual fatalities attributed to pollution-induced diseases. One emerging facet of environmental pollution is drug contamination, whereby pharmaceutical compounds can readily infiltrate water sources during manufacturing or utilization, subsequently being detected in various aquatic ecosystems. Some drugs have been detected in many watersheds at concentrations that can cause toxicity to aquatic organisms. Isavuconazonium sulfate (ISAV-SF), a prevalent antifungal medication, is no exception, warranting an exploration of its potential toxicity. However, limited research has been conducted in this domain. In this investigation, zebrafish were employed as a model organism to scrutinize the cardiotoxicity of ISAV-SF. Exposure of zebrafish embryos to concentrations of 0.5, 0.75, and 1 mg/L of ISAV-SF resulted in noteworthy cardiac developmental aberrations. These anomalies encompassed enlarged pericardial area, diminished heart rate, alterations in SV-BA distance, and the detachment of cardiomyocytes from the endocardium. Exposure to ISAV-SF caused disruption of the expression of genes related to cardiac development (<em>gata4, klf2a, nkx2.5, vmhc, tbx2b</em>), especially in the high concentration group. Moreover, the Notch signaling pathway was inhibited and oxidative stress levels were upregulated in all exposed groups. Remarkably, the administration of the antioxidant astaxanthin effectively mitigated oxidative stress levels, thus ameliorating heart developmental impairments. These results suggest that ISAV-SF may contribute to cardiac developmental defects by upregulating oxidative stress. This study serves as a pivotal reference for the utilization of ISAV-SF within the market, emphasizing the necessity to curtail its introduction into aquatic environments during production and consumption and to evaluate its repercussions on aquatic organisms.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111267"},"PeriodicalIF":4.7,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis of the femoral head by suppressing osteoclast activity through the reduction of cellular oxidative stress 抑制蛋白二硫异构酶可通过降低细胞氧化应激抑制破骨细胞的活性,从而减轻类固醇诱发的股骨头坏死。
IF 4.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-10 DOI: 10.1016/j.cbi.2024.111263
Xin Zhang , Changgong Feng , Tao Yuan , Yi Wang , Haojue Wang , Qizhen Lu , YongShuang Lv , Ziqing Li , Chuanyun Fu , Shui Sun
Osteonecrosis of the femoral head (ONFH) is a devastating and irreversible hip disease usually associated with increased oxidative stress due to the clinical application of high-dose or long-term glucocorticoids (GCs). Previous publications have demonstrated protein disulfide isomerase (PDI) plays a critical role in regulating cellular production of reactive oxygen species (ROS). We therefore ask whether interfering PDI could affect GCs-stimulated osteoclastogenesis. To test the hypothesis, we conducted bioinformatics and network analysis based on potential gene targets of steroid-induced osteonecrosis of the femoral head (SIONFH) in light of multiple databases and concomitantly verified the associated biological effect via the in vitro model of dexamethasone (DEX)-stimulated osteoclastogenesis. The results revealed 70 potential gene targets for SIONFH intervention, including the P4HB gene that encodes PDI. Further analysis based on network topology-based analysis techniques (NTA), protein-protein interaction (PPI) networks, and mouse cell atlas database identified the importance of PDI in regulating the cellular redox state of osteoclast during ONFH. Western blotting (WB) validations also indicated that PDI may be a positive regulator in the process of DEX-stimulated osteoclastogenesis. Hence, various PDI inhibitors were subjected to molecular docking with PDI and their performances were analyzed, including 3-Methyltoxoflavin (3 M) which inhibits PDI expression, and ribostamycin sulfate (RS) which represses PDI chaperone activity. The binding energies of DEX, 3 M, and RS to PDI were −5.3547, −4.2324, and −5.9917 kcal/mol, respectively. The Protein-Ligand Interaction Profiler (PLIP) analysis demonstrated that both hydrogen bonds and hydrophobic interactions were the key contributions to the DEX-PDI and 3M-PDI complexes, while only hydrogen bonds were identified as the predominant driving forces in the RS-PDI complex. Subsequent experiments showed that both 3 M and RS reduced osteoclast differentiation and bone resorption activity by stifling the expression of osteoclastic markers. This reduction was primarily due to the PDI inhibitors boosting the antioxidant system, thereby reducing the production of intracellular ROS. In conclusion, our results supported PDI's involvement in SIONFH progression by regulating ROS in osteoclasts and highlighted PDI inhibitors may serve as potential options for SIONFH treatment.
股骨头骨坏死(ONFH)是一种破坏性和不可逆的髋关节疾病,通常与临床应用大剂量或长期糖皮质激素(GCs)导致的氧化应激增加有关。以往的研究表明,蛋白二硫异构酶(PDI)在调节细胞产生活性氧(ROS)方面发挥着关键作用。因此,我们想知道干扰 PDI 是否会影响 GCs 刺激的破骨细胞生成。为了验证这一假设,我们根据多个数据库对类固醇诱导的股骨头坏死(SIONFH)的潜在基因靶点进行了生物信息学和网络分析,同时通过地塞米松(DEX)刺激破骨细胞生成的体外模型验证了相关的生物效应。结果发现了 70 个潜在的 SIONFH 干预基因靶点,其中包括编码 PDI 的 P4HB 基因。基于网络拓扑分析技术(NTA)、蛋白-蛋白相互作用(PPI)网络和小鼠细胞图谱数据库的进一步分析确定了PDI在ONFH过程中调节破骨细胞细胞氧化还原状态的重要性。Western印迹(WB)验证也表明,PDI可能是DEX刺激破骨细胞生成过程中的一个正向调节因子。因此,研究人员将多种 PDI 抑制剂与 PDI 进行了分子对接,并分析了它们的性能,包括抑制 PDI 表达的 3-甲基毒黄素(3M)和抑制 PDI 合子活性的硫酸核糖霉素(RS)。DEX、3M和RS与PDI的结合能分别为-5.3547、-4.2324和-5.9917 kcal/mol。蛋白质-配体相互作用剖析器(PLIP)分析表明,氢键和疏水相互作用是 DEX-PDI 和 3M-PDI 复合物的主要成分,而 RS-PDI 复合物中只有氢键是主要的驱动力。随后的实验表明,3M 和 RS 都能通过抑制破骨细胞标记物的表达来减少破骨细胞的分化和骨吸收活性。这种降低主要是由于 PDI 抑制剂增强了抗氧化系统,从而减少了细胞内 ROS 的产生。总之,我们的研究结果支持PDI通过调节破骨细胞中的ROS参与SIONFH的进展,并强调PDI抑制剂可能成为治疗SIONFH的潜在选择。
{"title":"Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis of the femoral head by suppressing osteoclast activity through the reduction of cellular oxidative stress","authors":"Xin Zhang ,&nbsp;Changgong Feng ,&nbsp;Tao Yuan ,&nbsp;Yi Wang ,&nbsp;Haojue Wang ,&nbsp;Qizhen Lu ,&nbsp;YongShuang Lv ,&nbsp;Ziqing Li ,&nbsp;Chuanyun Fu ,&nbsp;Shui Sun","doi":"10.1016/j.cbi.2024.111263","DOIUrl":"10.1016/j.cbi.2024.111263","url":null,"abstract":"<div><div>Osteonecrosis of the femoral head (ONFH) is a devastating and irreversible hip disease usually associated with increased oxidative stress due to the clinical application of high-dose or long-term glucocorticoids (GCs). Previous publications have demonstrated protein disulfide isomerase (PDI) plays a critical role in regulating cellular production of reactive oxygen species (ROS). We therefore ask whether interfering PDI could affect GCs-stimulated osteoclastogenesis. To test the hypothesis, we conducted bioinformatics and network analysis based on potential gene targets of steroid-induced osteonecrosis of the femoral head (SIONFH) in light of multiple databases and concomitantly verified the associated biological effect via the in vitro model of dexamethasone (DEX)-stimulated osteoclastogenesis. The results revealed 70 potential gene targets for SIONFH intervention, including the P4HB gene that encodes PDI. Further analysis based on network topology-based analysis techniques (NTA), protein-protein interaction (PPI) networks, and mouse cell atlas database identified the importance of PDI in regulating the cellular redox state of osteoclast during ONFH. Western blotting (WB) validations also indicated that PDI may be a positive regulator in the process of DEX-stimulated osteoclastogenesis. Hence, various PDI inhibitors were subjected to molecular docking with PDI and their performances were analyzed, including 3-Methyltoxoflavin (3 M) which inhibits PDI expression, and ribostamycin sulfate (RS) which represses PDI chaperone activity. The binding energies of DEX, 3 M, and RS to PDI were −5.3547, −4.2324, and −5.9917 kcal/mol, respectively. The Protein-Ligand Interaction Profiler (PLIP) analysis demonstrated that both hydrogen bonds and hydrophobic interactions were the key contributions to the DEX-PDI and 3M-PDI complexes, while only hydrogen bonds were identified as the predominant driving forces in the RS-PDI complex. Subsequent experiments showed that both 3 M and RS reduced osteoclast differentiation and bone resorption activity by stifling the expression of osteoclastic markers. This reduction was primarily due to the PDI inhibitors boosting the antioxidant system, thereby reducing the production of intracellular ROS. In conclusion, our results supported PDI's involvement in SIONFH progression by regulating ROS in osteoclasts and highlighted PDI inhibitors may serve as potential options for SIONFH treatment.</div></div>","PeriodicalId":274,"journal":{"name":"Chemico-Biological Interactions","volume":"404 ","pages":"Article 111263"},"PeriodicalIF":4.7,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chemico-Biological Interactions
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1